Larson Financial Group
KNSA icon

Larson Financial Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Larson Financial Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$80.4K Buy
1,077
+25
+2% +$1.84K ﹤0.01% 1357
2026
Q2 		$67.3K Buy
1,052
+4
+0.4% +$207 ﹤0.01% 1382
2026
Q1 		$50.5K Buy
1,048
+636
+154% +$28.2K ﹤0.01% 1347
2025
Q4 		$17K Buy
412
+75
+22% +$3.01K ﹤0.01% 1808
2025
Q3 		$13.1K Buy
+337
New +$10.9K ﹤0.01% 1882
2025
Q2 		– Sell
-33
Closed -$733 – 3400
2025
Q1 		$733 Buy
+33
New +$679 ﹤0.01% 2470

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Larson Financial Group's KNSA Position: Q3 2026 in Review

Larson Financial Group increased its Kiniksa Pharmaceuticals (KNSA) stake by 2.4% in Q3 2026, buying an estimated $1.84K and bringing the position to 1,077 shares worth $80.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1357.

Larson Financial Group first reported a position in KNSA in Q1 2025 and has held it in 6 quarters since. 149 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Larson Financial Group held 1,077 shares of Kiniksa Pharmaceuticals worth $80.4K as of Q3 2026.
  • Larson Financial Group bought 25 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $1.84K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1357 holding.
  • Larson Financial Group first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 149 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.